RxDoctor Payments Data

Kelly O'Shea, MD

Allergy & Immunology · Ann Arbor, MINPI 1427445022

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $350 of the $492 with a category attached, or 71.2%. Aimmune Therapeutics, Inc. accounts for 71.2% of it on its own, with 2 other manufacturers making up the rest. That places this record below the midpoint for allergy & immunology clinicians in MI, where the typical reported total is $2,234.

$492in general payments, 2019–2025

Across 4 payments — averaging $122.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Aimmune Therapeutics, Inc.$350
  • Regeneron Healthcare Solutions, Inc.$75
  • Novartis$66
$155,148in research payments, 2019–2025

Across 7 payments — averaging $22,164 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novartis$155K

What the payments were for

  • Speaking & faculty fees$35071%
  • Food & beverage$6613%
  • Education$7515%

General payments by program year

23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$492 in reported general payments places this provider in the 30th percentile of 119 allergy & immunology providers in Michigan.

See all allergy & immunology providers in Michigan

Medicare billing

Part B allowed, 2024
$1,208
Medicare patients
13
Services billed
263

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other allergy & immunology in Ann Arbor

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →